nach oben

Reactions Weekly

Erschienen in:

01.08.2020 | Case report

Ceftizoxime/moxifloxacin

Autoimmune haemolytic anaemia and nausea: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

In a case report, a 65-year-old man and a 64-year-old woman were described, who developed autoimmune haemolytic anaemia during treatment with ceftizoxime for pulmonary infection. Additionally, the woman developed nausea during treatment with moxifloxacin for pulmonary infection [not all duration of treatments to reactions onset and outcomes stated]. …

Wu S, et al. Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients. Journal of Clinical Pharmacy and Therapeutics 45: 812-814, No. 4, Aug 2020. Available from: URL: http://doi.org/10.1111/jcpt.13135

Titel: Ceftizoxime/moxifloxacin
Autoimmune haemolytic anaemia and nausea: 2 case reports
Publikationsdatum: 01.08.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-81733-1

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Ceftizoxime/moxifloxacin

Autoimmune haemolytic anaemia and nausea: 2 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Pembrolizumab

Tranexamic acid

Atezolizumab/guadecitabine

Clonidine/dexmedetomidine

Multiple drugs

Clozapine/haloperidol overdose